drugset / Trial / NCT00990015
A Phase 1 Single-Dose Escalation Study of PF-04308515 in Healthy Volunteers
RandomizedCrossoverDouble-blindBasic science
Summary
The purpose of this study is to determine the safety, tolerability, pharmacokinetics (understanding how a drug is absorbed and moves through the body) and pharmacodynamics (understanding the effects of a drug on certain target sites of activity in the body).
Timeline
- Start
- 2009-10
- Primary completion
- 2010-01
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-04308515 | Unknown | 0.1 mg | Oral |
| Subject | PF-04308515 | Unknown | 350 mg | Oral |
Indications
No indication recorded.